Patheon

Patheon is a premier global CDMO, now a core component of Thermo Fisher Scientific's Pharma Services business, offering a comprehensive suite of development and manufacturing capabilities across small molecules, biologics, and advanced therapies. Its strategic integration provides unmatched scale, supply chain resilience, and scientific expertise, positioning it as a critical enabler for the biopharmaceutical industry's most complex programs. The company's strategy focuses on leveraging Thermo Fisher's vast resources to expand capacity in high-growth modalities like viral vectors and mRNA, while driving operational excellence to solidify its position as a partner of choice for both emerging biotechs and large pharma.

Patheon's platform is an integrated suite of development, manufacturing, and clinical supply chain services for pharmaceuticals, biologics, and advanced therapies, supported by global regulatory expertise and specialized facilities.

Patheon competes with large, global CDMOs like Lonza and Catalent, as well as niche advanced therapy specialists. Its primary advantage is the scale, financial stability, and integrated service ecosystem provided by its parent company, Thermo Fisher Scientific, though it must balance this with maintaining a client-focused, agile service culture.